| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V64429 | Burosumab (KRN23) | 1610833-03-8 | Burosumab is a human FGF23 neutralizing antibody that may be utilized to study X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia. |
|
V62499 | Calpurbatug | 2635404-72-5 | Calpurbatug is an immunoglobulin G1 antibody. |
|
V64351 | Caplacizumab (ALX-0681; ALX-0081) | 915810-67-2 | Caplacizumab (ALX-0681) is a humanized anti-von Willebrand factor (vWF) nanobody. |
|
V56981 | Cedelizumab (RWJ 49004) | 156586-90-2 | Cedelizumab (RWJ 49004) is an IgG4 monoclonal antibody (mAb) targeting CD4. |
|
V62532 | Choriogonadotropin beta (FE 999302) | 2170458-11-2 | Choriogonadotropin beta (FE 999302) is a recombinant human chorionic gonadotropin (rhCG) expressed by a human cell line (PER.C6). |
|
V62030 | Cifurtilimab (SEA-CD40) | 1629760-27-5 | Cifurtilimab (SEA-CD40) is a humanized anti-CD40 IgG1 monoclonal antibody (mAb). |
|
V64465 | Cixutumumab (IMC-A12; NSC742460) | 947687-12-9 | Cixutumumab (IMC-A12) is a high-affinity humanized anti-IGF-1R monoclonal antibody (mAb) that can inhibit ligand-dependent receptor activation and downstream signaling. |
|
V62526 | Clenoliximab (IDEC-151) | 182912-58-9 | Clenoliximab (IDEC-151) is a macaque-human chimeric monoclonal antibody (mAb) (immunoglobulin G4) specific for the CD4 molecule on the surface of T lymphocytes. |
|
V62497 | Cofetuzumab (PF-06523435; hu24) | 1869928-62-0 | Cofetuzumab (PF-06523435) is a humanized IgG1-κ monoclonal antibody (mAb) targeting PTK7. |
|
V62027 | Concizumab (NN 7415; mAb 2021; Anti-TFPI Recombinant Antibody) | 1312299-39-0 | Concizumab is an anti-TFPI monoclonal antibody (mAb) (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 domain of TFPI, thereby blocking the interaction of this domain with the active site of FXa. |
|
V62568 | Crefmirlimab (89Zr-Df-IAB22M2C) | 2611099-93-3 | Crefmirlimab(89Zr-Df-IAB22M2C) is an anti-human CD8 probe targeting CD8 antigen and can be used for the diagnosis of a variety of cancers. |
|
V64575 | Crizanlizumab | 1690318-25-2 | Crizanlizumab is an anti-P-selectin (P-selectin) monoclonal antibody (mAb). |
|
V78896 | CTX-2026 | CTX-2026 is a pure human antibody that binds to CD277. | |
|
V58122 | Dalcinonacog alfa (CB-2679d; DalcA; ISU-304) | 2055206-13-6 | Dalcinonacog alfa is a recombinant FIX factor that may be utilized in study/research of hemophilia B. |
|
V59660 | Dalnicastobart (LVGN-7409) | 2642171-59-1 | Dalnicastobart (LVGN-7409) is a human IgG1κ antibody targeting CD40/TNFRSF5. |
|
V62531 | Dapirolizumab pegol (CDP 7657) | 1416147-64-2 | Dapirolizumab pegol (CDP 7657) is a Fab'-IgG-κ monoclonal antibody (mAb) targeting CD40LG/TNFSF5, conjugated with a pegol group. |
|
V59552 | Dargistotug (M-6223) | 2649362-29-6 | Dargistotug (M-6223) is a fully human IgG1 monoclonal antibody (mAb) targeting TIGIT (T cell immune receptor with Ig domain and ITIM). |
|
V62510 | Dazodalibep (MEDI 4920; VIB 4920) | 2245953-10-8 | Dazodalibep (MEDI 4920; VIB 4920) is a monoclonal antibody (mAb) targeting CD40LG/TNFSF5 fused to human serum albumin ALB/HSA. |
|
V59827 | Delpacibart | 2653183-66-3 | Delpacibart is a humanized, mouse IgG1κ antibody targeting TFRC. |
|
V60578 | Detumomab(SPECIFID) | 145832-33-3 | Detumomab is a mouse monoclonal antibody (mAb) targeting human B-cell lymphoma. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
